# FDA Inspection 1314386 - Grifols Bio Supplies Inc - April 23, 2026

Source: https://www.keypedia.com/records/fda_inspections/grifols-bio-supplies-inc/78a405e6-4305-44c3-89b8-e843a2009503
Source feed: FDA_Inspections

> FDA Inspection 1314386 for Grifols Bio Supplies Inc on April 23, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1314386
- Company Name: Grifols Bio Supplies Inc
- Inspection Date: 2026-04-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1206254 - 2023-05-19](https://www.keypedia.com/records/fda_inspections/grifols-bio-supplies-inc/7f9f39e6-72ce-4aa5-83cd-242c37bce155)
- [FDA Inspection 1083344 - 2019-03-14](https://www.keypedia.com/records/fda_inspections/grifols-bio-supplies-inc/8e9e93b2-0858-4ee5-8e60-4635465b213c)
- [FDA Inspection 999080 - 2016-10-14](https://www.keypedia.com/records/fda_inspections/grifols-bio-supplies-inc/f79adcdc-f4c5-4ccc-9c5d-bb89095d2cbb)
- [FDA Inspection 680693 - 2010-10-20](https://www.keypedia.com/records/fda_inspections/grifols-bio-supplies-inc/5cf731cd-40b0-4fa7-9863-484eb665faf6)

Company: https://www.keypedia.com/companies/grifols-bio-supplies-inc/191bdda0-81af-4a41-9274-400040704279

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d